MarketBeat on MSN
Ozempic, Mounjaro, Wegovy, or Zepbound? This ETF holds them all
After a lackluster first half of 2025, healthcare stocks staged a comeback, posting the best performance among the 11 S&P 500 ...
Several Vanguard ETFs are excellent candidates to soar in 2026. However, the Vanguard Information Technology ETF appears to ...
The VanEck Semiconductor ETF has been a top performer over the last decade, and is up about 40% this year. Paced by Nvidia, Taiwan Semi, and Broadcom, its holdings are delivering strong revenue growth ...
Amid the trying circumstances in the market right now, investors may be well served to target the best biotech ETFs to buy. Fundamentally, these exchange-traded funds benefit from permanent relevance.
This ETF is a “training ground” of sorts for a pair of popular funds. It's a sound idea for investors who want to diversify away from mega-cap stocks while maintaining growth exposure. This fund could ...
The Nasdaq-100 is in a raging bull market right now, after briefly slipping into bear territory back in April. Artificial intelligence (AI) stocks fueled its recovery, and they have been responsible ...
Wall Street recorded a subdued November this year. The S&P 500 lost 0.04% over the past month (as of Nov. 28, 2025), the Dow Jones advanced 0.8%, and the Nasdaq Composite was off 0.9%. The ebbing ...
Wall Street was downbeat last week. The S&P 500 index lost 1.95%, the Dow Jones index retreated 1.9% and the Nasdaq Composite slumped 2.7%. Overvaluation concerns in the artificial intelligence (AI) ...
Growth stock ETFs have led the market higher for much of the past decade. However, small-cap ETFs could outperform in a lower rate environment. It's possible that value stock ETFs could finally see ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results